US Patent 11382941 Gene therapy for treating Phenylketonuria
All edits
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
113829410
Date of Patent
July 12, 2022
0Patent Application Number
164749600
Date Filed
December 29, 2017
0Patent Citations
Patent Primary Examiner
Edits on 31 Mar, 2023
Golden AI
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
113829410
Date of Patent
July 12, 2022
0Patent Application Number
164749600
Date Filed
December 29, 2017
0Patent Citations
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Edits on 13 Jul, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
Article (+241 characters)
US Patent 11382941 Gene therapy for treating Phenylketonuria
Article
Compositions and regimens useful in treating phenylketonuria are provided. The compositions include recombinant adeno-associated virus (rAAV) with a transthyretin enhancer and promoter driving expression of a human phenylalanine hydroxylase.
Infobox
Is a
Patent jurisdiction
Patent number
11382941
Date of patent
July 12, 2022
Patent application number
16474960
Date Filed
December 29, 2017
Patent primary examiner
Find more entities like US Patent 11382941 Gene therapy for treating Phenylketonuria
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.